Rhythm Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RYTM and other ETFs, options, and stocks.About RYTM
Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with rare diseases. The firm offers IMCIVREE (setmelanotide), a precision medicine designed to treat hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) diseases.
CEODavid P. Meeker
CEODavid P. Meeker
Employees283
Employees283
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2008
Founded2008
Employees283
Employees283
RYTM Key Statistics
Market cap6.36B
Market cap6.36B
Price-Earnings ratio-31.88
Price-Earnings ratio-31.88
Dividend yield—
Dividend yield—
Average volume615.87K
Average volume615.87K
High today$97.05
High today$97.05
Low today$94.39
Low today$94.39
Open price$96.50
Open price$96.50
Volume230.16K
Volume230.16K
52 Week high$106.52
52 Week high$106.52
52 Week low$45.91
52 Week low$45.91
Analyst ratings
93%
of 15 ratingsBuy
93.3%
Hold
6.7%
Sell
0%
People also own
Based on the portfolios of people who own RYTM. This list is generated using Robinhood data, and it’s not a recommendation.